CF PharmTech Files Application for H Share Full Circulation with CSRC
I'm PortAI, I can summarize articles.
CF PharmTech, Inc. has filed an application with the China Securities Regulatory Commission (CSRC) for H Share Full Circulation, converting 107,408,422 domestic unlisted shares into H Shares on a one-for-one basis. Once approved, these shares will be listed on the Hong Kong Stock Exchange. The company has not yet applied for the conversion and listing, and further announcements will follow as progress is made.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments